Employer-mandated obstructive sleep apnea treatment and healthcare cost savings among truckers
Open Access
- 15 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 43 (4)
Abstract
To evaluate the effect of an employer-mandated obstructive sleep apnea (OSA) diagnosis and treatment program on non-OSA-program trucker medical insurance claim costs. Retrospective cohort analysis; cohorts constructed by matching (randomly, with replacement) Screen-positive Controls (drivers with insurance screened as likely to have OSA, but not yet diagnosed) with Diagnosed drivers (n = 1,516; cases = 1,224, OSA Negatives = 292), on two factors affecting exposure to medical claims: experience level at hire and weeks of job tenure at the Diagnosed driver’s polysomnogram (PSG) date (the “matching date”). All cases received auto-adjusting positive airway pressure (APAP) treatment and were grouped by objective treatment adherence data: any “Positive Adherence” (n = 932) versus “No Adherence” (n = 292). Bootstrap resampling produced a difference-in-differences estimate of aggregate non-OSA-program medical insurance claim cost savings for 100 Diagnosed drivers as compared to 100 Screen-positive Controls before and after the PSG/matching date, over an 18-month period. A two-part multivariate statistical model was used to set exposures and demographics/anthropometrics equal across sub-groups, and to generate a difference-in-differences comparison across periods that identified the effect of OSA treatment on per-member per-month (PMPM) costs of an individual driver, separately from cost differences associated with adherence choice. Eighteen-month non-OSA-program medical claim costs savings from diagnosing (and treating as required) 100 Screen-positive Controls: $153,042 (95% CI: −$5,352, $330,525). Model-estimated effect of treatment on those adhering to APAP: −$441 PMPM (95% CI: −$861, −$21). Results suggest a carrier-based mandatory OSA program generates substantial savings in non-OSA-program medical insurance claim costs.Keywords
Funding Information
- National Institutes of Health (#UL1 RR 025758)
- National Surface Transportation Safety Center for Excellence (12-UI-017)
This publication has 53 references indexed in Scilit:
- Effect of Sleep Apnea and Continuous Positive Airway Pressure on Cardiac Structure and Recurrence of Atrial FibrillationJournal of the American Heart Association, 2013
- The reciprocal interaction between obesity and obstructive sleep apnoeaSleep Medicine Reviews, 2013
- The More the Merrier? Working Towards Multidisciplinary Management of Obstructive Sleep Apnea and Comorbid InsomniaJournal of Clinical Psychology, 2013
- Cost Savings Associated with an Education Campaign on the Diagnosis and Management of Sleep-Disordered Breathing: A Retrospective, Claims-Based US StudyPopulation Health Management, 2013
- Economic Implications of Sleep DisordersPharmacoEconomics, 2010
- Cognitive skills affect economic preferences, strategic behavior, and job attachmentProceedings of the National Academy of Sciences, 2009
- Consensus Criteria for Screening Commercial Drivers for Obstructive Sleep Apnea: Evidence of EfficacyJournal of Occupational and Environmental Medicine, 2008
- Obstructive sleep apnea and coronary artery diseaseSleep Medicine Reviews, 2008
- The Evolving Concept of the Healthy Worker Survivor EffectEpidemiology, 1994
- Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical AccuracyStatistical Science, 1986